MOH Quote, Financials, Valuation and Earnings

The Cigna Group has a net margin of 2.39% compared to Molina Healthcare's net margin of 2.17%. Molina Healthcare's return on equity of 25.84% beat The Cigna Group's return on equity of 8.07%.

Molina Healthcare has a consensus price target of $338.46, signalling downside risk potential of -2.38%. On the other hand The Cigna Group has an analysts' consensus of $362.55 which suggests that it could grow by 12.45%. Given that The Cigna Group has higher upside potential than Molina Healthcare, analysts believe The Cigna Group is more attractive than Molina Healthcare.

Molina Healthcare has a beta of 0.701, which suggesting that the stock is 29.866% less volatile than S&P 500. In comparison The Cigna Group has a beta of 0.506, suggesting its less volatile than the S&P 500 by 49.385%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Cigna Group offers a yield of 1.77% to investors and pays a quarterly dividend of $1.51 per share. Molina Healthcare pays -- of its earnings as a dividend. The Cigna Group pays out 45.63% of its earnings as a dividend. The Cigna Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare quarterly revenues are $10.5B, which are smaller than The Cigna Group quarterly revenues of $65.7B. Molina Healthcare's net income of $251M is lower than The Cigna Group's net income of $1.4B. Notably, Molina Healthcare's price-to-earnings ratio is 16.97x while The Cigna Group's PE ratio is 26.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.49x versus 0.37x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.

Centene has a net margin of 2.39% compared to Molina Healthcare's net margin of 0.69%. Molina Healthcare's return on equity of 25.84% beat Centene's return on equity of 12.3%.

Molina Healthcare has a consensus price target of $338.46, signalling downside risk potential of -2.38%. On the other hand Centene has an analysts' consensus of $78.62 which suggests that it could grow by 26.96%. Given that Centene has higher upside potential than Molina Healthcare, analysts believe Centene is more attractive than Molina Healthcare.

Molina Healthcare has a beta of 0.701, which suggesting that the stock is 29.866% less volatile than S&P 500. In comparison Centene has a beta of 0.529, suggesting its less volatile than the S&P 500 by 47.066%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Molina Healthcare pays -- of its earnings as a dividend. Centene pays out -- of its earnings as a dividend.

Molina Healthcare quarterly revenues are $10.5B, which are smaller than Centene quarterly revenues of $40.8B. Molina Healthcare's net income of $251M is lower than Centene's net income of $283M. Notably, Molina Healthcare's price-to-earnings ratio is 16.97x while Centene's PE ratio is 9.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.49x versus 0.20x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health has a net margin of 2.39% compared to Molina Healthcare's net margin of 0.92%. Molina Healthcare's return on equity of 25.84% beat Elevance Health's return on equity of 14.4%.

Molina Healthcare has a consensus price target of $338.46, signalling downside risk potential of -2.38%. On the other hand Elevance Health has an analysts' consensus of $498.18 which suggests that it could grow by 16.16%. Given that Elevance Health has higher upside potential than Molina Healthcare, analysts believe Elevance Health is more attractive than Molina Healthcare.

Molina Healthcare has a beta of 0.701, which suggesting that the stock is 29.866% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.773, suggesting its less volatile than the S&P 500 by 22.685%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health offers a yield of 1.54% to investors and pays a quarterly dividend of $1.71 per share. Molina Healthcare pays -- of its earnings as a dividend. Elevance Health pays out 25.22% of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare quarterly revenues are $10.5B, which are smaller than Elevance Health quarterly revenues of $45.4B. Molina Healthcare's net income of $251M is lower than Elevance Health's net income of $418M. Notably, Molina Healthcare's price-to-earnings ratio is 16.97x while Elevance Health's PE ratio is 16.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.49x versus 0.56x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of 2.39% compared to Molina Healthcare's net margin of 5.5%. Molina Healthcare's return on equity of 25.84% beat UnitedHealth Group's return on equity of 14.34%.

Molina Healthcare has a consensus price target of $338.46, signalling downside risk potential of -2.38%. On the other hand UnitedHealth Group has an analysts' consensus of $628.30 which suggests that it could grow by 19.67%. Given that UnitedHealth Group has higher upside potential than Molina Healthcare, analysts believe UnitedHealth Group is more attractive than Molina Healthcare.

Molina Healthcare has a beta of 0.701, which suggesting that the stock is 29.866% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.607, suggesting its less volatile than the S&P 500 by 39.293%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group offers a yield of 1.6% to investors and pays a quarterly dividend of $2.10 per share. Molina Healthcare pays -- of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare quarterly revenues are $10.5B, which are smaller than UnitedHealth Group quarterly revenues of $100.8B. Molina Healthcare's net income of $251M is lower than UnitedHealth Group's net income of $5.5B. Notably, Molina Healthcare's price-to-earnings ratio is 16.97x while UnitedHealth Group's PE ratio is 33.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.49x versus 1.22x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.